CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions | Total | Common Stock | Additional Paid-in Capital | Retained Earnings (Accumulated Deficit) |
Beginning balance (in shares) at Dec. 31, 2021 | | 117,917,349 | | |
Beginning of period at Dec. 31, 2021 | $ 5,671 | $ 1 | $ 4,845 | $ 825 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Issuance of common stock for Marcellus Acquisition (in shares) | | 9,442,185 | | |
Issuance of common stock for Marcellus Acquisition | 764 | | 764 | |
Share-based compensation (in shares) | | 23,169 | | |
Share-based compensation | 5 | | 5 | |
Issuance of common stock for warrant exercise (in shares) | | 669,669 | | |
Issuance of common stock for warrant exercise | $ 1 | | 1 | |
Repurchase and retirement of common stock (in shares) | (1,000,000) | (1,000,000) | | |
Repurchase and retirement of common stock | $ (83) | | | (83) |
Net income (loss) | (764) | | | (764) |
Dividends on common stock | (211) | | | (211) |
Ending balance (in shares) at Mar. 31, 2022 | | 127,052,372 | | |
End of period at Mar. 31, 2022 | 5,383 | $ 1 | 5,615 | (233) |
Beginning balance (in shares) at Dec. 31, 2021 | | 117,917,349 | | |
Beginning of period at Dec. 31, 2021 | 5,671 | $ 1 | 4,845 | 825 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net income (loss) | 473 | | | |
Ending balance (in shares) at Jun. 30, 2022 | | 121,590,256 | | |
End of period at Jun. 30, 2022 | 5,808 | $ 1 | 5,619 | 188 |
Beginning balance (in shares) at Dec. 31, 2021 | | 117,917,349 | | |
Beginning of period at Dec. 31, 2021 | $ 5,671 | $ 1 | 4,845 | 825 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Repurchase and retirement of common stock (in shares) | (13,904,000) | | | |
Repurchase and retirement of common stock | $ (1,248) | | | |
Ending balance (in shares) at Jun. 30, 2023 | | 132,684,741 | | |
End of period at Jun. 30, 2023 | 10,396 | $ 1 | 5,726 | 4,669 |
Beginning balance (in shares) at Mar. 31, 2022 | | 127,052,372 | | |
Beginning of period at Mar. 31, 2022 | 5,383 | $ 1 | 5,615 | (233) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Share-based compensation (in shares) | | 146,054 | | |
Share-based compensation | 3 | | 3 | |
Issuance of common stock for warrant exercise (in shares) | | 166,606 | | |
Issuance of common stock for warrant exercise | $ 1 | | 1 | |
Issuance of reserved common stock and warrants (in shares) | | 36,951 | | |
Repurchase and retirement of common stock (in shares) | (5,812,000) | (5,811,727) | | |
Repurchase and retirement of common stock | $ (515) | | | (515) |
Net income (loss) | 1,237 | | | 1,237 |
Dividends on common stock | (301) | | | (301) |
Ending balance (in shares) at Jun. 30, 2022 | | 121,590,256 | | |
End of period at Jun. 30, 2022 | 5,808 | $ 1 | 5,619 | 188 |
Beginning balance (in shares) at Dec. 31, 2022 | | 134,715,094 | | |
Beginning of period at Dec. 31, 2022 | 9,124 | $ 1 | 5,724 | 3,399 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Share-based compensation (in shares) | | 92,048 | | |
Share-based compensation | $ 5 | | 5 | |
Issuance of common stock for warrant exercise (in shares) | | 4,654 | | |
Repurchase and retirement of common stock (in shares) | (793,000) | (792,543) | | |
Repurchase and retirement of common stock | $ (60) | | | (60) |
Net income (loss) | 1,389 | | | 1,389 |
Dividends on common stock | (175) | | | (175) |
Ending balance (in shares) at Mar. 31, 2023 | | 134,019,253 | | |
End of period at Mar. 31, 2023 | 10,283 | $ 1 | 5,729 | 4,553 |
Beginning balance (in shares) at Dec. 31, 2022 | | 134,715,094 | | |
Beginning of period at Dec. 31, 2022 | 9,124 | $ 1 | 5,724 | 3,399 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Issuance of common stock for warrant exercise (in shares) | | 5,532 | | |
Net income (loss) | 1,780 | | | |
Ending balance (in shares) at Jun. 30, 2023 | | 132,684,741 | | |
End of period at Jun. 30, 2023 | 10,396 | $ 1 | 5,726 | 4,669 |
Beginning balance (in shares) at Mar. 31, 2023 | | 134,019,253 | | |
Beginning of period at Mar. 31, 2023 | 10,283 | $ 1 | 5,729 | 4,553 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Share-based compensation (in shares) | | 109,012 | | |
Share-based compensation | $ 7 | | 7 | |
Issuance of common stock for warrant exercise (in shares) | | 878 | | |
Repurchase and retirement of common stock (in shares) | (1,444,000) | (1,444,402) | | |
Repurchase and retirement of common stock | $ (125) | | (10) | (115) |
Net income (loss) | 391 | | | 391 |
Dividends on common stock | (160) | | | (160) |
Ending balance (in shares) at Jun. 30, 2023 | | 132,684,741 | | |
End of period at Jun. 30, 2023 | $ 10,396 | $ 1 | $ 5,726 | $ 4,669 |